268 related articles for article (PubMed ID: 12821939)
1. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
Chamboredon S; Briggs J; Vial E; Hurault J; Galvagni F; Oliviero S; Bos T; Castellazzi M
Oncogene; 2003 Jun; 22(26):4047-61. PubMed ID: 12821939
[TBL] [Abstract][Full Text] [Related]
2. v-Jun downregulates the alpha 2 (I) collagen target gene indirectly through Sp1/3.
Chamboredon S; Castellazzi M
Oncogene; 2005 Apr; 24(15):2547-57. PubMed ID: 15735704
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
Vial E; Perez S; Castellazzi M
Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
5. Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3.
Gaudreault M; Vigneault F; Leclerc S; Guérin SL
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3490-505. PubMed ID: 17652716
[TBL] [Abstract][Full Text] [Related]
6. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo.
Vial E; Castellazzi M
Oncogene; 2000 Mar; 19(14):1772-82. PubMed ID: 10777211
[TBL] [Abstract][Full Text] [Related]
8. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
9. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
10. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
Heegaard AM; Xie Z; Young MF; Nielsen KL
J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
[TBL] [Abstract][Full Text] [Related]
14. Nectin-2 expression in testicular cells is controlled via the functional cooperation between transcription factors of the Sp1, CREB, and AP-1 families.
Lui WY; Sze KL; Lee WM
J Cell Physiol; 2006 Apr; 207(1):144-57. PubMed ID: 16250013
[TBL] [Abstract][Full Text] [Related]
15. Differential and antagonistic effects of v-Jun and c-Jun.
Gao M; Morgan I; Vogt PK
Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
[TBL] [Abstract][Full Text] [Related]
16. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.
Hartl M; Reiter F; Bader AG; Castellazzi M; Bister K
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13601-6. PubMed ID: 11698665
[TBL] [Abstract][Full Text] [Related]
17. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
18. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
Sif S; Capobianco AJ; Gilmore TD
Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
[TBL] [Abstract][Full Text] [Related]
19. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
20. Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells.
Li T; Chen YH; Liu TJ; Jia J; Hampson S; Shan YX; Kibler D; Wang PH
Circ Res; 2003 Dec; 93(12):1202-9. PubMed ID: 14593001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]